1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimization of allogeneic hematopoietic cell transplantation for patients with myelofibrosis treated with ruxolitinib: Eligibility, best practices, and improving transplant outcomes
    Review

    Wall, S. A.; Tamari, R.; DeFilipp, Z.; Hobbs, G. S.
    Annals of Hematology (2025)

    Fulltext@MSK | Save
  • Mutant IDH1 cooperates with NPM1c or FLT3(ITD) to drive distinct myeloid diseases and molecular outcomes
    Journal Article

    Sakamoto, T.; Leca, J.; Zhang, X.; Meydan, C.; Foox, J.; Ramachandran, P.; Hendrikse, L. D.; Zhou, W.; Berger, T.; Fortin, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2025)

    Fulltext@MSK | Save
  • A human antibody specific for SIRPα reprograms macrophages and promotes antibody mediated anti-cancer activity
    Journal Article

    Kurtz, K. G.; Lebedeva, I.; Pierre, S. A.; Andrew, D.; Liao, Y. R.; Ambriz, D.; Vergnolle, O.; Shen, L.; Nyakatura, E.; Baca, M.; more...
    PLoS ONE (2025)

    Fulltext@MSK | Save
  • Muscleblind-like proteins are novel modulators of the tumor-immune microenvironment
    Journal Article

    Gabel, A. M.; Crosse, E. I.; Belleville, A. E.; Hogg, S. J.; McKellar, S. A.; Abdel-Wahab, O.; Thomas, J. D.; Bradley, R. K.
    PLoS ONE (2025)

    Fulltext@MSK | Save
  • Oncoral follow-up for outpatients treated with oral anticancer drugs assessed by relative dose intensity
    Journal Article

    Larbre, V.; Ranchon, F.; Maucort-Boulch, D.; Coz, E.; Herledan, C.; Caffin, A. G.; Baudouin, A.; Maire, M.; Romain-Scelle, N.; Vacheron, C. H.; more...
    Pharmaceuticals (2025)

    Fulltext@MSK | Save
  • Targeting the tumor and the immune system in smoldering multiple myeloma
    Editorial

    Maura, F.; Bergsagel, P. L.
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: A first-in-human, single-centre, phase 1 trial
    Journal Article

    Lou, E.; Choudhry, M. S.; Starr, T. K.; Folsom, T. D.; Bell, J.; Rathmann, B.; DeFeo, A. P.; Kim, J.; Slipek, N.; Jin, Z.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment
    Journal Article

    Zhang, P.; Whipp, E. C.; Skuli, S. J.; Gharghabi, M.; Saygin, C.; Sher, S. A.; Carroll, M.; Pan, X.; Eisenmann, E. D.; Lai, T. H.; more...
    Journal of Clinical Investigation (2025)

    Fulltext@MSK | Save
  • Multiple myeloma, version 1.2025 featured updates to the NCCN guidelines®
    Guidelines

    Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L. D. Jr; Baljevic, M.; Baz, R.; Campagnaro, E.; Costello, C.; D’Angelo, C.; Derman, B.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Impact of clonal hematopoiesis on solid tumor progression following radiation therapy
    Journal Article

    Tao, J. J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save